Adult-onset Still’s disease: Switch to atypical skin manifestations under anakinra therapy

• Henning Klapproth, MD,
• Birte Stroucken, MD,
• Doris Helbig, MD,
• Iliana Tantcheva-Poór, MD,
• Mario Fabri, MD

Affiliations

Henning Klapproth, MD

Department of Dermatology and Venereology, Faculty of Medicine, University of Cologne, University Hospital of Cologne, Cologne, Germany; Correspondence to: Henning Klapproth, MD, Faculty of Medicine, Department of Dermatology and Venereology, University of Cologne, University Hospital of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.

Birte Stroucken, MD

Department of Dermatology and Venereology, Faculty of Medicine, University of Cologne, University Hospital of Cologne, Cologne, Germany

Doris Helbig, MD

Department of Dermatology and Venereology, Faculty of Medicine, University of Cologne, University Hospital of Cologne, Cologne, Germany

Iliana Tantcheva-Poór, MD

Department of Dermatology and Venereology, Faculty of Medicine, University of Cologne, University Hospital of Cologne, Cologne, Germany

Mario Fabri, MD

Department of Dermatology and Venereology, Faculty of Medicine, University of Cologne, University Hospital of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany